The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Thoracic Oncology

• Publication date

  2011-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/JTO.0b013e3182037b76PMID 21173711
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The hallmarks of cancer

  2012cited by this paper
• Immune infiltration in human tumors: a prognostic factor that should not be ignored

  2010cited by this paper
• The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time

  2010cited by this paper
• Tumor-Infiltrating Foxp3+ Regulatory T Cells are Correlated with Cyclooxygenase-2 Expression and are Associated with Recurrence in Resected Non-small Cell Lung Cancer

  2010cited by this paper
• The prognostic value of intraepithelial and stromal CD3‐, CD117‐ and CD138‐positive cells in non‐small cell lung carcinoma

  2010cited by this paper
• Prognostic relevance of soluble human leukocyte antigen-G and total human leukocyte antigen class I molecules in lung cancer patients.

  2010cited by this paper
• Combination of low vascular endothelial growth factor A (VEGF‐A)/VEGF receptor 2 expression and high lymphocyte infiltration is a strong and independent favorable prognostic factor in patients with nonsmall cell lung cancer

  2010cited by this paper
• The number and microlocalization of tumor-associated immune cells are associated with patient's survival time in non-small cell lung cancer

  2010cited by this paper
• Clinical relevance and functional implications for human leucocyte antigen-g expression in non-small-cell lung cancer

  2009cited by this paper
• Microenvironmental regulation of metastasis

  2009cited by this paper
• A Central Role for Foxp3+ Regulatory T Cells in K-Ras-Driven Lung Tumorigenesis

  2009cited by this paper
• Immunotherapy in non-small-cell lung carcinoma: from inflammation to vaccination.

  2009cited by this paper
• Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.

  2009cited by this paper
• Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival

  2009cited by this paper
• The prognostic value of intraepithelial and stromal innate immune system cells in non‐small cell lung carcinoma

  2009cited by this paper
• Human Dendritic Cells Produce TGF-β1 under the Influence of Lung Carcinoma Cells and Prime the Differentiation of CD4+CD25+Foxp3+ Regulatory T Cells1

  2009cited by this paper
• Mesenchymal stem cells in health and disease

  2008cited by this paper
• Functions of natural killer cells

  2008cited by this paper
• Dendritic cell infiltration pattern along the colorectal adenoma‐carcinoma sequence  

  2008cited by this paper
• Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/macrophages

  2008cited by this paper
• CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer.

  2008cited by this paper
• Cancer: Inflaming metastasis

  2008cited by this paper
• The Significance and Relationship between Mast Cells and Tumour Angiogenesis in Non-small Cell Lung Carcinoma

  2008cited by this paper
• Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice1

  2008cited by this paper
• Cancer-related inflammation

  2008cited by this paper
• The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages.

  2008cited by this paper
• Malignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancer.

  2008cited by this paper
• Immune surveillance: a balance between protumor and antitumor immunity.

  2008cited by this paper
• Immune escape as a fundamental trait of cancer: focus on IDO

  2008cited by this paper
• NK cells and cancer immunosurveillance

  2008cited by this paper
• Predominant infiltration of macrophages and CD8+ T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer

  2008cited by this paper
• Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.

  2008cited by this paper
• The future of cancer vaccines for non-small-cell lung cancer: ongoing trials.

  2008cited by this paper
• Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non–Small Cell Lung Cancer

  2008cited by this paper
• “Re-educating” tumor-associated macrophages by targeting NF-κB

  2008cited by this paper
• Beyond the increasing complexity of the immunomodulatory HLA-G molecule.

  2008cited by this paper
• Early clinical trial experience with vaccine therapies in non-small-cell lung cancer.

  2008cited by this paper
• The role of myeloid cells in the promotion of tumour angiogenesis

  2008cited by this paper
• The Plasticity of γδ T Cells: Innate Immunity, Antigen Presentation and New Immunotherapy

  2008cited by this paper
• Exploring the full spectrum of macrophage activation

  2008cited by this paper
• Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells

  2008cited by this paper
• Natural killer cells infiltrating human nonsmall‐cell lung cancer are enriched in CD56brightCD16− cells and display an impaired capability to kill tumor cells

  2008cited by this paper
• Pulmonary stromal cells induce the generation of regulatory DC attenuating T‐cell‐mediated lung inflammation

  2008cited by this paper
• CD8+ Foxp3+ Regulatory T Cells Mediate Immunosuppression in Prostate Cancer

  2007cited by this paper
• L-BLP25: A Peptide Vaccine Strategy in Non–Small Cell Lung Cancer

  2007cited by this paper
• Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels.

  2007cited by this paper
• Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression.

  2007cited by this paper
• Final results of a multi-center, double-blind, randomized, placebo-controlled phase II study to assess the efficacy of MAGE-A3 immunotherapeutic as adjuvant therapy in stage IB/II non-small cell lung cancer (NSCLC)

  2007cited by this paper
• Altered macrophage differentiation and immune dysfunction in tumor development.

  2007cited by this paper
• Inflammatory cell infiltration of tumors: Jekyll or Hyde

  2007cited by this paper
• Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors

  2007cited by this paper
• Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer.

  2007cited by this paper
• Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

  2007cited by this paper
• Natural killer cells: from CD3(-)NKp46(+) to post-genomics meta-analyses.

  2007cited by this paper
• NKT cells in immunoregulation of tumor immunity: a new immunoregulatory axis.

  2007cited by this paper
• Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer.

  2007cited by this paper
• Bv8 regulates myeloid-cell-dependent tumour angiogenesis

  2007cited by this paper
• Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

  2007cited by this paper
• Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma

  2006cited by this paper
• Macrophages: obligate partners for tumor cell migration, invasion, and metastasis.

  2006cited by this paper
• Expression of Foxp3 in non-small cell lung cancer patients is significantly higher in tumor tissues than in normal tissues, especially in tumors smaller than 30 mm.

  2006cited by this paper
• Non-Classical HLA-G Antigen and Its Role in the Cancer Progression

  2006cited by this paper
• Cancer despite immunosurveillance: immunoselection and immunosubversion

  2006cited by this paper
• Paradoxical roles of the immune system during cancer development

  2006influential reference
• Suppression of Antitumor Immunity by IL-10 and TGF-β-Producing T Cells Infiltrating the Growing Tumor: Influence of Tumor Environment on the Induction of CD4+ and CD8+ Regulatory T Cells1

  2006cited by this paper
• Tumor infiltrating Foxp3+ regulatory T‐cells are associated with recurrence in pathologic stage I NSCLC patients

  2006cited by this paper
• Dendritic cell infiltration and prognosis of human hepatocellular carcinoma

  2006cited by this paper
• T cell memory.

  2006cited by this paper
• Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse.

  2006cited by this paper
• Fibroblasts in cancer

  2006influential reference
• The global health burden of infection‐associated cancers in the year 2002

  2006cited by this paper
• p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance.

  2006cited by this paper
• Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer.

  2005cited by this paper
• NK cells in innate immunity.

  2005cited by this paper
• Monocyte and macrophage heterogeneity

  2005cited by this paper
• Smoldering and polarized inflammation in the initiation and promotion of malignant disease.

  2005cited by this paper
• Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer.

  2005cited by this paper
• Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.

  2005cited by this paper
• Close encounters of different kinds: Dendritic cells and NK cells take centre stage

  2005cited by this paper
• De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent.

  2005cited by this paper
• Dendritic cell maturation by innate lymphocytes

  2005cited by this paper
• The interplay between innate and adaptive immunity regulates cancer development

  2005cited by this paper
• Macrophage polarization comes of age.

  2005cited by this paper
• Tie2 identifies a hematopoietic monocytes required for tumor lineage of proangiogenic vessel formation and a mesenchymal population of pericyte progenitors

  2005cited by this paper
• VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

  2005cited by this paper
• Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer.

  2005cited by this paper
• Immunosuppressive networks in the tumour environment and their therapeutic relevance

  2005cited by this paper
• The interface between innate and adaptive immunity

  2004cited by this paper
• Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

  2004cited by this paper
• Mast cell contribution to angiogenesis related to tumour progression

  2004cited by this paper
• The chemokine system in diverse forms of macrophage activation and polarization.

  2004cited by this paper
• Interplay of natural killer cells and their receptors with the adaptive immune response

  2004cited by this paper
• Natural killer lymphocytes: biology, development, and function

  2004cited by this paper
• Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future

  2004cited by this paper
• Toll-like receptor signalling

  2004cited by this paper
• Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma

  2004cited by this paper
• Derangement of immune responses by myeloid suppressor cells

  2004cited by this paper
• Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis.

  2004cited by this paper
• Tumour-educated macrophages promote tumour progression and metastasis

  2004cited by this paper
• CD1a-positive infiltrating-dendritic cell density and 5-year survival from human breast cancer

  2003cited by this paper

• Liver stem cell tumorigenesis in gilthead sea bream induced by B[a]P toxicity: In vitro insights.

  2026cites this paper
• Incremental prognostic value of immune cell densities beyond clinical parameters in non-small cell lung cancer.

  2026cites this paper
• A data-driven cartography of NSCLC vaccine research: Quantifying the paradigm shift toward immuno-oncology combination therapies

  2026cites this paper
• Multimodal CT radiomics combined with machine learning algorithms to differentiate benign from malignant pulmonary nodules

  2026cites this paper
• To Study the Neutrophil Lymphocyte Ratio As a Predictive Marker of Response to Neoadjuvant Chemotherapy in Locally Advanced Triple-Negative Breast Cancer

  2026cites this paper
• A long-term survival prediction model for non-small cell lung cancer based on blood inflammatory biomarkers

  2026cites this paper
• Systematic Analysis of CA9 as a Pan-Cancer Marker for Prognosis and Immunity

  2025cites this paper
• Radiomics-based decision support tool with ground-glass opacity status of 5-year survival prediction for early-stage non-small cell lung cancer

  2025cites this paper
• The Role of Lymphocyte Recovery Index in Prognosis Prediction for Locally Advanced Cervical Cancer With Radiation‐Induced Lymphopenia

  2025cites this paper
• VPS26A as a Prognostic Biomarker and Therapeutic Target in Liver Hepatocellular Carcinoma: Insights from Comprehensive Bioinformatics Analysis

  2025cites this paper
• Comprehensive analysis of heat shock protein 110, 90, 70, 60 families and tumor immune microenvironment characterization in clear cell renal cell carcinoma

  2025cites this paper
• Safety, efficacy, and analysis of biomarkers in patients with advanced non-small cell lung cancer treated with the anti-IL1RAP antibody nadunolimab (CAN04) in combination with platinum doublet

  2025cites this paper
• Tumour Single‐Cell Bioinformatics: From Immune Profiling to Molecular Dynamics

  2025cites this paper
• The roles of Cryptochrome-1: the circadian clock as a control point in cancer therapy

  2025cites this paper
• Mitigation of benzo(a)pyrene-induced hepatotoxicity and oxidative damage in Nile tilapia (Oreochromis niloticus) using N-acetylcysteine-loaded starch nanoparticles in porous alginate beads through the CYP1A/Nrf2/HO-1 pathway

  2025cites this paper
• T lymphocyte heterogeneity in NSCLC: implications for biomarker development and therapeutic innovation

  2025cites this paper
• Diallyl Trisulfide Suppresses Tumor‐Associated Macrophage M2‐Like Polarization and Recruitment and Improves the Tumor Microenvironment Through Blocking CCL5/STAT3 Signaling Pathway Against Lung Cancer

  2025cites this paper
• Predicting targeted therapy resistance in non-small cell lung cancer using multimodal machine learning

  2025cites this paper
• Role of the “inflammation-immunity-metabolism” network in non-small cell lung cancer: a multi-omics analysis

  2025cites this paper
• Identification and predictive machine learning model construction of gut microbiota associated with carcinoembryonic antigens in colorectal cancer

  2025cites this paper
• Prognostic value of baseline LIPI, LDH and dNLR in ES-SCLC patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis

  2025cites this paper
• Radiation therapy-induced normal tissue damage: involvement of EMT pathways and role of FLASH-RT in reducing toxicities

  2025cites this paper
• Variation in CBC-Derived Inflammatory Biomarkers Across Histologic Subtypes of Lung Cancer: Can Histology Guide Clinical Management?

  2025cites this paper
• RadioFlow Cytometry Reveals That [18F]FDG Uptake in K-RAS Lung Cancer Is Driven by Immune Cells: An Analysis on a Single-Cell Level

  2025cites this paper
• Multi-Omics and Functional Analysis of BFSP1 as a Prognostic and Therapeutic Target in Liver Hepatocellular Carcinoma

  2025cites this paper
• A mathematical model to study low-dose metronomic scheduling for chemotherapy.

  2024cites this paper
• Low densities of immune cells indicate unfavourable overall survival in patients suffering from squamous cell carcinoma of the lung

  2024cites this paper
• Tumor Characteristics and Treatment Responsiveness in Pembrolizumab-Treated Non-Small Cell Lung Carcinoma

  2024cites this paper
• ACE2: the node connecting the lung cancer and COVID-19.

  2024cites this paper
• Identification and validation of a novel anoikis‐related prognostic model for prostate cancer

  2024cites this paper
• Research Progress on the Correlation between Lung Cancer and Tumor Inflammatory Microenvironment

  2024cites this paper
• Prognostic Significance of T Lymphocytes in Immunotherapy for Non-Small Cell Lung Cancer

  2024cites this paper
• Correlation of Increased Soluble Tumor Necrosis Factor Receptor 1 with Mortality and Dependence on Treatment in Non-Small-Cell Lung Cancer Patients: A Longitudinal Cohort Study

  2024cites this paper
• 3D cell culture models in research: applications to lung cancer pharmacology

  2024cites this paper
• Enhanced Proteomic Coverage in Tissue Microenvironment by Immune Cell Subtype Library-Assisted DIA-MS

  2024cites this paper
• Characterizing immune infiltration in esthesioneuroblastoma subtypes through gene expression deconvolution.

  2024cites this paper
• Global trends in tertiary lymphoid structures: a bibliometric analysis from 2014 to 2023

  2024cites this paper
• Peripheral Inflammation Featuring Eosinophilia or Neutrophilia Is Associated with the Survival and Infiltration of Eosinophils within the Tumor among Various Histological Subgroups of Patients with NSCLC

  2024cites this paper
• Causal relationships between immune cell phenotypes and lung adenocarcinoma: A bidirectional two‐sample Mendelian randomization study

  2024cites this paper
• Real-world retrospective study of anti-PD-1 antibody in combination with chemotherapy as a neoadjuvant treatment strategy for locally advanced resectable esophageal squamous cell carcinoma

  2024cites this paper
• NOLC1 was identified as a tumor suppressor gene in thyroid cancer and correlated with prognosis by bioinformatics.

  2024cites this paper
• Analysis of differences in intestinal flora associated with different BMI status in colorectal cancer patients

  2024cites this paper
• Novel genetic variants in the NLRP3 inflammasome-related PANX1 and APP genes predict survival of patients with hepatitis B virus-related hepatocellular carcinoma

  2024cites this paper
• The Past and Future of Inflammation as a Target to Cancer Prevention.

  2024cites this paper
• Identification and predictive machine learning models construction of gut microbiota associated with lymph node metastasis in colorectal cancer

  2024cites this paper
• The predictive value of neutrophil-to-lymphocyte ratio for overall survival and pathological complete response in breast cancer patients receiving neoadjuvant chemotherapy

  2023cites this paper
• Transforming growth factor-β (TGF-β) signaling pathway-related genes in predicting the prognosis of colon cancer and guiding immunotherapy

  2023cites this paper
• An immune-related prognostic gene ULBP2 is correlated with immunosuppressive tumor microenvironment and immunotherapy in breast cancer

  2023cites this paper
• Survival and soluble immune mediators of immune checkpoint inhibitor-induced interstitial lung disease in patients with non-small cell lung cancer.

  2023cites this paper
• Machine learning-identified stemness features and constructed stemness-related subtype with prognosis, chemotherapy, and immunotherapy responses for non-small cell lung cancer patients

  2023cites this paper
• The value of CDC42 effector protein 2 as a novel prognostic biomarker in liver hepatocellular carcinoma: a comprehensive data analysis

  2023cites this paper
• Genomic and immunogenomic analysis of three prognostic signature genes in LUAD

  2023cites this paper
• A novel immunogenomic classification for prognosis in non-small cell lung cancer

  2023cites this paper
• New-generation cytopharmaceuticals with powerfully boosted extravasation for enhanced cancer therapy.

  2023cites this paper
• Prognostic factors and clinical outcomes in patients with relapsed acute leukemia after allogeneic hematopoietic stem cell transplantation

  2023cites this paper
• Clinical outcome and biomarker assessments of a multi-centre phase II trial assessing niraparib with or without dostarlimab in recurrent endometrial carcinoma

  2023cites this paper
• Blood-Derived Systemic Inflammation Markers and Risk of Nodal Failure in Stage Ia Non-Small Cell Lung Cancer: A Multicentric Study

  2023cites this paper
• A novel anoikis-related gene signature to predict the prognosis, immune infiltration, and therapeutic outcome of lung adenocarcinoma

  2023cites this paper
• Multi-omics immune regulatory mechanisms in lung adenocarcinoma metastasis and survival time

  2023cites this paper
• Survival and biomarkers for cachexia in non‐small cell lung cancer receiving immune checkpoint inhibitors

  2023cites this paper
• Radiomics and deep learning models to differentiate lung adenosquamous carcinoma: A multicenter trial

  2023cites this paper
• Identification of immune cell infiltration profiles in renal cell carcinoma and their clinical significance

  2023cites this paper
• CCL2, CCL8, CXCL12 chemokines in resectable non-small cell lung cancer (NSCLC).

  2023cites this paper
• Immune infiltration in tumor and adjacent non-neoplastic regions co-determines patient clinical outcomes in early-stage lung cancer.

  2023cites this paper
• Development of a risk model based on immune genes in patients with colon adenocarcinoma

  2022cites this paper
• A novel immune-related lncRNA pair signature for prognostic prediction and immune response evaluation in gastric cancer: a bioinformatics and biological validation study

  2022cites this paper
• Twenty-Year Survival of Patients Operated on for Non-Small-Cell Lung Cancer: The Impact of Tumor Stage and Patient-Related Parameters

  2022cites this paper
• AIM2 upregulation promotes metastatic progression and PD‐L1 expression in lung adenocarcinoma

  2022cites this paper
• Spatially variant immune infiltration scoring in human cancer tissues

  2022cites this paper
• Assessment of systemic immune-inflammation index in predicting postoperative pulmonary complications in patients undergoing lung cancer resection.

  2022cites this paper
• Transcriptional patterns reveal tumor histologic heterogeneity and immunotherapy response in lung adenocarcinoma

  2022cites this paper
• Correlation between hematological parameters and PET/CT metabolic parameters in patients with head and neck cancer

  2022cites this paper
• ADRB2 expression predicts the clinical outcomes and is associated with immune cells infiltration in lung adenocarcinoma

  2022cites this paper
• THBS2 is Closely Related to the Poor Prognosis and Immune Cell Infiltration of Gastric Cancer

  2022cites this paper
• Development and validation of a combined ferroptosis- and pyroptosis-related gene signatures for the prediction of clinical outcomes in lung adenocarcinoma.

  2022cites this paper
• Targeting interleukin-1β and inflammation in lung cancer

  2022cites this paper
• Outcomes of lung metastasis from pancreatic cancer: A nationwide multicenter analysis

  2022cites this paper
• Pan-cancer analysis of the angiotensin II receptor-associated protein as a prognostic and immunological gene predicting immunotherapy responses in pan-cancer

  2022cites this paper
• Transcriptome-guided resolution of tumor microenvironment interactions in pheochromocytoma and paraganglioma subtypes

  2022cites this paper
• Tumor-promoting inflammation in lung cancer: A literature review

  2022cites this paper
• The Impact of Resolution of Inflammation on Tumor Microenvironment: Exploring New Ways to Control Cancer Progression

  2022cites this paper
• Recent Advancements of Monotherapy, Combination, and Sequential Treatment of EGFR/ALK-TKIs and ICIs in Non–Small Cell Lung Cancer

  2022cites this paper
• An immunosuppressive scoring system to predict recurrence and assist in decision regarding postoperative adjuvant treatment in gastric cancer.

  2022cites this paper
• The application of the Glasgow prognostic score to predict the survival in patients with metastatic pancreatic carcinoma

  2022cites this paper
• Clinical, Laboratory, Histological, Radiological, and Metabolic Features and Prognosis of Malignant Pleural Mesothelioma

  2022cites this paper
• Relationship between Tumor Infiltrating Immune Cells and Tumor Metastasis and Its Prognostic Value in Cancer

  2022cites this paper
• Tissue Proteogenomic Landscape Reveals the Role of Uncharacterized SEL1L3 in Progression and Immunotherapy Response in Lung Adenocarcinoma.

  2022cites this paper
• The Molecular and Cellular Strategies of Glioblastoma and Non-Small-Cell Lung Cancer Cells Conferring Radioresistance

  2022cites this paper
• Spontaneous Regression of Cancer: Revealing Granulocytes and Oxidative Stress as the Crucial Double-edge Sword.

  2022cites this paper
• Transcriptional expression and prognostic roles of MCM7 in human bladder, breast, and lung cancers: a multi-omics analysis

  2022cites this paper
• Immune Infiltration Analysis with the CIBERSORT Method in Lung Cancer

  2022cites this paper
• Identification and validation of RB1 as an immune-related prognostic signature based on tumor mutation burdens in bladder cancer

  2022cites this paper
• Inflammation Related to Obesity in the Etiopathogenesis of Gastroenteropancreatic Neuroendocrine Neoplasms

  2022cites this paper
• The Predictive Value of Pretreatment Lactate Dehydrogenase and Derived Neutrophil-to-Lymphocyte Ratio in Advanced Non-Small Cell Lung Cancer Patients Treated With PD-1/PD-L1 Inhibitors: A Meta-Analysis

  2022cites this paper
• Elevated air quality index and fine particulate matter levels contribute to the poor prognosis and progression of nonsmall‐cell lung cancer: A cohort study combined with external validation

  2022cites this paper
• [Establishment of a prediction model for colorectal cancer immune cell infiltration based on the cancer genome atlas (TCGA) database].

  2022cites this paper
• Zinc transporter LIV1: A promising cell surface target for triple negative breast cancer

  2022cites this paper
• Adenoviral CD40 Ligand Immunotherapy in 32 Canine Malignant Melanomas–Long-Term Follow Up

  2021cites this paper
• Identification of immune-infiltrating cell-related biomarkers in hepatocellular carcinoma based on gene co-expression network analysis

  2021cites this paper
• Drug discovery oncology in a mouse: concepts, models and limitations

  2021cites this paper